EFFICACY OF MAGNESIUM SULPHATE ON MATERNAL MORBIDITY AND MORTALITY IN ECLAMPSIA

Objective: To study efficacy of Magnesium Sulphate in reducing maternal morbidity and mortality in patients presenting with eclampsia. Study Design: Prospective observational study. Place and Duration of Study: Gynae/Obs Department, Combined Military Hospital Bannu, from Jan 2018 Sep 2019....

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Nadia Arif, Raja Qaseem Ahmed, Bushra Zafar, Farrukh Shehzad
Formato:	article
Lenguaje:	EN
Publicado:	Army Medical College Rawalpindi 2021
Materias:	eclampsia magnesium sulphate maternal morbidity maternal mortality pulmonary edema Medicine R Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/7ee96aba507f427baa725d143614757e
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:7ee96aba507f427baa725d143614757e
record_format	dspace
spelling	oai:doaj.org-article:7ee96aba507f427baa725d143614757e2021-12-02T18:01:40ZEFFICACY OF MAGNESIUM SULPHATE ON MATERNAL MORBIDITY AND MORTALITY IN ECLAMPSIA0030-96482411-884210.51253/pafmj.v71i2.4100https://doaj.org/article/7ee96aba507f427baa725d143614757e2021-04-01T00:00:00Zhttps://pafmj.org/index.php/PAFMJ/article/view/4100https://doaj.org/toc/0030-9648https://doaj.org/toc/2411-8842Objective: To study efficacy of Magnesium Sulphate in reducing maternal morbidity and mortality in patients presenting with eclampsia. Study Design: Prospective observational study. Place and Duration of Study: Gynae/Obs Department, Combined Military Hospital Bannu, from Jan 2018 Sep 2019. Methodology: A total of 134 patients fulfilling inclusion criteria were included in the study. Patient management was multidisciplinary. Convulsions were controlled by 4gram magnesium sulphate intravenously over 20 minutes as a loading dose, followed by 1gram per hour of maintenance infusion. Blood pressure was controlled with injection Labetalol 10 milligram followed by injection Hydralazine repeated after every 20 minutes till the blood pressure was controlled. Results: A total of 134 patients had eclampsia constituting 6.8% of obstetric admissions. Case fatality was 14 (10.4%) while 120 (89.55%) of the cases responded well to treatment and survived the event. Mean age of patients was 22 years. Thirty patients 22.4% were booked and 104 patients 77.6% were un-booked. Mostly patients 122 (91%) came from rural area and only 12 (9%) were from urban areas with booked pregnancies having regular antenatal visits. One hundred and twenty six (94%) patients with eclampsia presented in antenatal period and only 8 (6%) presented in post natal period. Mode of delivery was cesarean section in 87 (64.9%) and 47 (35.1%) delivered vaginally. Frequency of patient requiring ventilator support, acute renal failure, disseminated intravascular coagulation, adult respiratory distress syndrome, HELLP (hemolysis, elevated liver enzymes, low platelet) syndrome was 11 (8.2%), 46 (34.3%), 43 (32.1%), 35 (26.1%), 7 (5.2%) respectively..........Nadia ArifRaja Qaseem AhmedBushra ZafarFarrukh ShehzadArmy Medical College Rawalpindiarticleeclampsiamagnesium sulphatematernal morbiditymaternal mortalitypulmonary edemaMedicineRMedicine (General)R5-920ENPakistan Armed Forces Medical Journal, Vol 71, Iss 2, Pp 598-601 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	eclampsia magnesium sulphate maternal morbidity maternal mortality pulmonary edema Medicine R Medicine (General) R5-920
spellingShingle	eclampsia magnesium sulphate maternal morbidity maternal mortality pulmonary edema Medicine R Medicine (General) R5-920 Nadia Arif Raja Qaseem Ahmed Bushra Zafar Farrukh Shehzad EFFICACY OF MAGNESIUM SULPHATE ON MATERNAL MORBIDITY AND MORTALITY IN ECLAMPSIA
description	Objective: To study efficacy of Magnesium Sulphate in reducing maternal morbidity and mortality in patients presenting with eclampsia. Study Design: Prospective observational study. Place and Duration of Study: Gynae/Obs Department, Combined Military Hospital Bannu, from Jan 2018 Sep 2019. Methodology: A total of 134 patients fulfilling inclusion criteria were included in the study. Patient management was multidisciplinary. Convulsions were controlled by 4gram magnesium sulphate intravenously over 20 minutes as a loading dose, followed by 1gram per hour of maintenance infusion. Blood pressure was controlled with injection Labetalol 10 milligram followed by injection Hydralazine repeated after every 20 minutes till the blood pressure was controlled. Results: A total of 134 patients had eclampsia constituting 6.8% of obstetric admissions. Case fatality was 14 (10.4%) while 120 (89.55%) of the cases responded well to treatment and survived the event. Mean age of patients was 22 years. Thirty patients 22.4% were booked and 104 patients 77.6% were un-booked. Mostly patients 122 (91%) came from rural area and only 12 (9%) were from urban areas with booked pregnancies having regular antenatal visits. One hundred and twenty six (94%) patients with eclampsia presented in antenatal period and only 8 (6%) presented in post natal period. Mode of delivery was cesarean section in 87 (64.9%) and 47 (35.1%) delivered vaginally. Frequency of patient requiring ventilator support, acute renal failure, disseminated intravascular coagulation, adult respiratory distress syndrome, HELLP (hemolysis, elevated liver enzymes, low platelet) syndrome was 11 (8.2%), 46 (34.3%), 43 (32.1%), 35 (26.1%), 7 (5.2%) respectively..........
format	article
author	Nadia Arif Raja Qaseem Ahmed Bushra Zafar Farrukh Shehzad
author_facet	Nadia Arif Raja Qaseem Ahmed Bushra Zafar Farrukh Shehzad
author_sort	Nadia Arif
title	EFFICACY OF MAGNESIUM SULPHATE ON MATERNAL MORBIDITY AND MORTALITY IN ECLAMPSIA
title_short	EFFICACY OF MAGNESIUM SULPHATE ON MATERNAL MORBIDITY AND MORTALITY IN ECLAMPSIA
title_full	EFFICACY OF MAGNESIUM SULPHATE ON MATERNAL MORBIDITY AND MORTALITY IN ECLAMPSIA
title_fullStr	EFFICACY OF MAGNESIUM SULPHATE ON MATERNAL MORBIDITY AND MORTALITY IN ECLAMPSIA
title_full_unstemmed	EFFICACY OF MAGNESIUM SULPHATE ON MATERNAL MORBIDITY AND MORTALITY IN ECLAMPSIA
title_sort	efficacy of magnesium sulphate on maternal morbidity and mortality in eclampsia
publisher	Army Medical College Rawalpindi
publishDate	2021
url	https://doaj.org/article/7ee96aba507f427baa725d143614757e
work_keys_str_mv	AT nadiaarif efficacyofmagnesiumsulphateonmaternalmorbidityandmortalityineclampsia AT rajaqaseemahmed efficacyofmagnesiumsulphateonmaternalmorbidityandmortalityineclampsia AT bushrazafar efficacyofmagnesiumsulphateonmaternalmorbidityandmortalityineclampsia AT farrukhshehzad efficacyofmagnesiumsulphateonmaternalmorbidityandmortalityineclampsia
_version_	1718378936926208000

EFFICACY OF MAGNESIUM SULPHATE ON MATERNAL MORBIDITY AND MORTALITY IN ECLAMPSIA

Ejemplares similares